Epidemiology of MRSA and current strategies in Europe and Japan

Area of Science:

• Infectious Diseases
• Hospital Epidemiology
• Public Health Policy

Background:

• Health-care associated infections (HAIs) caused by multi-drug resistant organisms (MDROs), particularly Methicillin-resistant Staphylococcus aureus (MRSA), have increased significantly.
• The rising prevalence of MRSA infections leads to severe patient consequences, prolonged treatment, and substantial economic burdens on European healthcare systems.

Purpose of the Study:

• To provide an overview of the current MRSA situation in selected European countries and Japan.
• To identify and discuss potential strategies for preventing MRSA infections and their dissemination.
• To explore future prospects for MRSA control in healthcare settings.

Main Methods:

• A workshop was convened at the 8th International Congress of the German Society of Hospital Hygiene in Berlin.
• A 20-question survey was distributed to country representatives covering epidemiology, current measures, and future prospects.
• Responses from various European countries and Japan were collected and analyzed.

Main Results:

• MRSA prevalence is increasing across all surveyed European countries and Japan.
• The rate of increase varies, with lower trends observed in The Netherlands, Slovenia, France, Austria, and Scandinavian countries.
• Significant differences in reported prevention strategies and current measures were noted among the participants.

Conclusions:

• Unified and strengthened prevention strategies are crucial for the European Community to combat the rising tide of MRSA.
• Rapid screening methods, such as Polymerase Chain Reaction (PCR), could aid in MRSA prevention efforts.
• Implementing infection control management requirements for hospital contracts with health insurance providers is a potential strategy to enhance control measures.